# Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology

> **NCT03409120** · NA · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 38 (actual)

## Conditions studied

- Dystonia-Parkinsonism, Adult-Onset
- Parkinson Disease

## Interventions

- **DEVICE:** Boston Scientific Vercise PC IPG with directional DBS lead

## Key facts

- **NCT ID:** NCT03409120
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2022-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03409120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03409120, "Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03409120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*